Keyphrases
Immunocompromised Patients
100%
Acyclovir
100%
Cytomegalovirus Disease
100%
Placebo
14%
Cytomegalovirus
14%
Mantel
14%
Breslow
14%
Randomized Placebo-controlled Trial
7%
Cytomegalovirus Infection
7%
Plasma Concentration
7%
Treatment Study
7%
Viremia
7%
Renal Transplant Recipients
7%
First Day
7%
Renal Allograft
7%
Clinical Response
7%
Fast Rates
7%
Bacteroides Fragilis
7%
Rapid Rate
7%
Drug Infusion
7%
Renal Allograft Recipient
7%
First Dose
7%
Improvement Factor
7%
Defervescence
7%
Organ Transplant Recipients
7%
In Vitro Testing
7%
Afebrile
7%
Number of Patients
7%
Placebo Groups
7%
Medicine and Dentistry
Cytomegalovirus Infection
100%
Immunocompromised Patient
100%
Aciclovir
100%
Placebo
28%
Kidney Allograft
14%
Cytomegalovirus
14%
In Vitro
7%
Kidney Graft
7%
Viremia
7%
Drug Infusion
7%
Bacteroides fragilis
7%
Side Effect
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cytomegalovirus Infection
100%
Aciclovir
100%
Immunocompromised Patient
100%
Placebo
28%
Cytomegalovirus
14%
Bacteroides fragilis
7%
Viremia
7%
Side Effect
7%
Immunology and Microbiology
Cytomegalovirus
100%
Immunocompromised Patient
100%
Allograft
40%
Cytomegalovirus Infection
20%
Blood Plasma
20%
Bacteroides fragilis
20%
Viremia
20%
Susceptibility
20%
In Vitro
20%